Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)
Hong Kong · Delayed Price · Currency is HKD 56.15
+5.45 (10.75%)
At close: Jan 21, 2026
HKG:6609 Market Cap
HKG:6609 has a market cap or net worth of 2.13 billion as of January 21, 2026. Its market cap has increased by 146.87% in one year.
Market Cap
2.13B
Enterprise Value
1.40B
Revenue
367.02M
Ranking
n/a
PE Ratio
45.94
Stock Price
56.15
Market Cap Chart
Since August 20, 2021, HKG:6609's market cap has decreased from 5.01B to 2.13B, a decrease of -57.43%. That is a compound annual growth rate of -17.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.93B | -6.13% |
| Dec 31, 2025 | 2.05B | 145.03% |
| Dec 31, 2024 | 837.20M | -26.22% |
| Dec 29, 2023 | 1.13B | -19.93% |
| Dec 30, 2022 | 1.42B | -65.18% |
| Dec 31, 2021 | 4.07B | -18.76% |
| Aug 20, 2021 | 5.01B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |